Mepifiline
CAS57383-74-1
Mepifiline (CAS 57383-74-1, C26H33N7O5) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 57383-74-1
- Formula
- C26H33N7O5
- Mol. weight
- 523.58 g/mol
Chemical Specifications
Identifiers
| CAS number | 57383-74-1 |
|---|---|
| Product name | Mepifiline |
| Chinese name | 美哌芬宁 |
| Synonyms | Mepifiline; Mepyramine theophylline acetate; 1,2,3,6-Tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purine-7-acetic acid,compound with N-(p-methoxybenzyl)-N',N'-dimethyl-N-(2-pyridyl)eth ane-1,2-diamine (1:1); 7H-Purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethy |
| Molecular formula | C26H33N7O5 |
| Molecular weight | 523.58 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of Mepifiline?
The CAS Registry Number of Mepifiline is 57383-74-1. Mepifiline is also known as Mepifiline; Mepyramine theophylline acetate; 1,2,3,6-Tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purine-7-acetic acid,compound with N-(p-methoxybenzyl)-N',N'-dimethyl-N-(2-pyridyl)eth ane-1,2-diamine (1:1).
What is the molecular formula and molecular weight of Mepifiline?
The molecular formula of Mepifiline is C26H33N7O5, and its molecular weight is 523.58 g/mol.
How can I request a quotation for Mepifiline?
Send an inquiry for Mepifiline (CAS 57383-74-1) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for Mepifiline
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.